Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis (vol 179, pg 867, 2019)

被引：0
|
作者：
Sawaya, G. F.
Sanstead, E.
Alarid-Escudero, F.
机构：
来源：
JAMA INTERNAL MEDICINE | 2019年 / 179卷 / 08期
关键词：
D O I：
10.1001/jamainternmed.2019.2564
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1152 / 1152
页数：1
相关论文
共 30 条
  • [1] Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis
    Sawaya, George F.
    Sanstead, Erinn
    Alarid-Escudero, Fernando
    Smith-McCune, Karen
    Gregorich, Steven E.
    Silverberg, Michael J.
    Leyden, Wendy
    Huchko, Megan J.
    Kuppermann, Miriam
    Kulasingam, Shalini
    JAMA INTERNAL MEDICINE, 2019, 179 (07) : 867 - 878
  • [2] A DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS OF CERVICAL CANCER SCREENING STRATEGIES IN ENGLAND
    van Hest, N.
    Griffiths, M.
    VALUE IN HEALTH, 2023, 26 (06) : S68 - S68
  • [3] Cost-effectiveness of cervical-cancer screening in developing countries (vol 354, pg 1535, 2006)
    Goldie
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (07): : 745 - 745
  • [4] Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness (vol 285, pg 3107, 2001)
    Goldie, SJ
    Kuhn, L
    Denny, L
    Pollack, A
    Wright, TC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (09): : 1026 - 1026
  • [5] A cost-effectiveness analysis of prenatal screening strategies for down syndrome (vol 106, pg 562, 2005)
    Odibo, A
    Stamilio, DM
    Nelson, DB
    Sehdev, HM
    Macones, GA
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (01): : 209 - 209
  • [6] Policy analysis of cervical cancer screening strategies in low-resource settings - Clinical benefits and cost-effectiveness
    Goldie, SJ
    Kuhn, L
    Denny, L
    Pollack, A
    Wright, TC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (24): : 3107 - 3115
  • [7] Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes
    M. J. Hassett
    H. Li
    H. J. Burstein
    R. S. Punglia
    Breast Cancer Research and Treatment, 2020, 181 : 43 - 51
  • [8] Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes
    Hassett, M. J.
    Li, H.
    Burstein, H. J.
    Punglia, R. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (01) : 43 - 51
  • [9] Cost-effectiveness analysis of alternative screening strategies for the detection of cervical cancer among women in rural areas of Western Kenya
    Lobin, Christopher
    Orang'o, Elkanah Omenge
    Were, Edwin
    Muthoka, Kapten
    Singh, Kavita
    De Allegri, Manuela
    Obermann, Konrad
    Doeberitz, Magnus von Knebel
    Bussmann, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (07) : 1257 - 1267
  • [10] Computed Tomography Screening for Lung Cancer in the National Lung Screening Trial: A Cost-effectiveness Analysis (vol 30, pg 79, 2015)
    Black, W. C.
    JOURNAL OF THORACIC IMAGING, 2015, 30 (05) : W59 - W59
123